Skip to main content
. 2020 Dec 14;2020:6782659. doi: 10.1155/2020/6782659

Figure 3.

Figure 3

(a) Expression of mRNA for STC-2 in CVeD (chronic venous disease) and HV (healthy controls) in arbitrary units. (b, c) Images showing the immunostaining for STC-2 in CVD patients in the three tunics of the venous wall (asterisk) and CV. I: intimate robe; M: middle robe; A: adventitious robe. ∗∗∗p < 0.001.